They found that APS-1 significantly reduced insulin levels in type 1 diabetic (T1D) mice and improved the intestinal barrier function by regulating the expression of ZO-1, Occludin, and Claudin-1. The gene discussed is CLDN1; the disease is type 1 diabetes mellitus.